Can Cells Help Interstitial Lung Disease?

Interstitial Lung Disease is an umbrella term used to classify a family of about 100 diverse types of pulmonary conditions that impede the normal absorption of oxygen in the lungs. All of these conditions have an effect the interstitium, which is the tissue and space around the alveoli—the cluster-like air sacs—in the lungs. The interstitium is usually relatively invisible, but when an individual has interstitial lung disease, the interstitium becomes progressively scarred and more visible. This scarring is characteristic of the entire family of diseases encompassed by interstitial lung disease. The scar tissue affects the ability for oxygen to pass from the lungs into the bloodstream. Before today, the effects of interstitial lung disease were irreversible; now cellular therapy for interstitial lung disease offers a new, practical option for people affected by the condition.

Therapy for Interstitial Lung Disease

To this day, interstitial lung disease is—unfortunately—incurable, but that does not mean that it is not able to be treated. In fact, there are many treatments out there for interstitial lung disease, but these do not actually reduce any of the effects of interstitial lung disease. As an incurable disorder, the therapy is not meant to make the disease disappear, but rather therapy can be used to improve an individual’s quality of life, to reduce symptoms or to prevent the ongoing progression of the disease. Upon diagnosis, many physicians utilize a combination of medications to suppress the immune system, but these have not proven successful. In order to help patients who are struggling to breathe, compressed oxygen can help manage shortness of breath. There are times that pulmonary rehabilitation and nutritional counseling are recommended in order to improve endurance. In severe cases, pulmonologists may resort to a lung transplant, but this invasive procedure often has limited availability and extensive requirements for eligibility. Thankfully, there is a new possibility as a result of the hard work of a visionary group of doctors dedicated to improving the lives of patients with interstitial lung disease.

What are Cells?

Cells are the building blocks of every single living organism in the world. They have the ability for self-renewal and replication, and are capable of forming any type of tissue or organ in the body. Cells from one organ are able to create tissue for another organ; this is called plasticity. It has been discovered that adult cells have the ability to be transferred into any single organ in the body.

Cellular Therapy for Interstitial Lung Disease

In the case of interstitial lung disease, autologous cells are used; this means the cells come from the patient’s body. These cells are found in blood. Blood cells have the capacity to form many types of differentiated cells. During the procedure, cellular therapy involves isolating cells requiring special laboratory techniques to collect. After extraction, the cells are isolated. At this point, the cells are returned to the patient intravenously. The minimally invasive therapy can be performed as an outpatient procedure in a clinical setting under the supervision of a professional. It takes a physician that has sought specific training to perform cellular therapy adequately, safely and successfully. If you would like to find out more about how our cellular therapy for interstitial lung disease can help you, please contact one of our patient care coordinators today at 888-745-6697 to schedule a free consultation.

 

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.